Q87.3
Congenital malformation syndromes involving early overgrowth
Clinical Classification Guidelines
Inclusion Terms
- Beckwith-Wiedemann syndrome
- Sotos syndrome
- Weaver syndrome
Medical Intelligence & Overview
Congenital malformation syndromes involving early overgrowth are a group of rare genetic disorders characterized by excessive growth and developmental irregularities present from birth. These syndromes include Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome. They can affect various parts of the body, leading to distinctive physical features and increasing the risk of certain health complications. Early diagnosis and management are vital to addressing the unique challenges associated with these conditions.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting growth-regulating genes such as those in the 11p15 chromosomal region (Beckwith-Wiedemann syndrome). Mutations in the NSD1 gene, associated with Sotos syndrome. Mutations in the EZH2 gene, linked to Weaver syndrome. Possible epigenetic changes that influence gene activity without altering the DNA sequence.
Key Symptoms: Excessive growth in height and size during childhood. Large for gestational age at birth. Distinctive facial features such as a prominent forehead, elongated face, or a broad nasal root. Abnormalities of organ size or function, such as kidney or liver anomalies. Developmental delays or intellectual disabilities in some cases. Increased risk of certain tumors, such as Wilms tumor or hepatoblastoma. Overlapping features like macroglossia (enlarged tongue) in Beckwith-Wiedemann syndrome. Skeletal abnormalities and joint hyperflexibility. Advanced bone age that might not correspond to chronological age. Possible facial asymmetry or congenital anomalies.
Diagnostic & Treatment
Diagnosis Path: Physical examination to identify characteristic features. Growth measurements over time to assess overgrowth patterns. Chromosomal and genetic testing to detect specific gene mutations or chromosomal alterations. Ultrasound imaging during pregnancy or after birth to evaluate organ development. Tumor screening procedures due to increased cancer risk. Neurodevelopmental assessments if developmental delays are suspected.
Treatment Protocols: Regular surveillance for early detection and treatment of associated tumors. Growth regulation therapies, if deemed appropriate. Surgical interventions to correct congenital anomalies or organ issues. Developmental support services such as speech therapy, physical therapy, or educational assistance. Monitoring and managing associated health problems, including cardiovascular, renal, or endocrine issues. Genetic counseling for families to understand the condition and recurrence risks. Psychosocial support to assist with coping and developmental challenges.
Clinical Advice & FAQs
Billing Guidance
Is Q87.3 a billable ICD-10 code?
Yes, Q87.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q87.3?
Clinical documentation must specify the nature of Congenital malformation syndromes involving early overgrowth and any associated comorbidities for accurate reporting.
Cite this Clinical Reference